Wirtz Mathijs R, Jurgens Jordy, Zuurbier Coert J, Roelofs Joris J T H, Spinella Philip C, Muszynski Jennifer A, Carel Goslings J, Juffermans Nicole P
Department of Intensive Care Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, Amsterdam, The Netherlands.
Transfusion. 2019 Jan;59(1):134-145. doi: 10.1111/trf.15039. Epub 2018 Nov 21.
Transfusion is associated with organ failure and nosocomial infection in trauma patients, which may be mediated by soluble bioactive substances in blood products, including extracellular vesicles (EVs). We hypothesize that removing EVs, by washing or filtering of blood products, reduces organ failure and improves host immune response.
Blood products were prepared from syngeneic rat blood. EVs were removed from RBCs and platelets by washing. Plasma was filtered through a 0.22-μm filter. Rats were traumatized by crush injury to the intestines and liver, and a femur was fractured. Rats were hemorrhaged until a mean arterial pressure of 40 mm Hg and randomized to receive resuscitation with standard or washed/filtered blood products, in a 1:1:1 ratio. Sham controls were not resuscitated. Ex vivo whole blood stimulation tests were performed and histopathology was done.
Washing of blood products improved quality metrics compared to standard products. Also, EV levels reduced by 12% to 77%. The coagulation status, as assessed by thromboelastometry, was deranged in both groups and normalized during transfusion, without significant differences. Use of washed/filtered products did not reduce organ failure, as assessed by histopathologic score and biochemical measurements. Immune response ex vivo was decreased following transfusion compared to sham but did not differ between transfusion groups.
Filtering or washing of blood products improved biochemical properties and reduced EV counts, while maintaining coagulation abilities. However, in this trauma and transfusion model, the use of optimized blood components did not attenuate organ injury or immune suppression.
输血与创伤患者的器官衰竭和医院感染相关,这可能由血液制品中的可溶性生物活性物质介导,包括细胞外囊泡(EVs)。我们假设通过对血液制品进行洗涤或过滤去除EVs可减少器官衰竭并改善宿主免疫反应。
血液制品由同基因大鼠血液制备。通过洗涤从红细胞和血小板中去除EVs。血浆通过0.22μm过滤器过滤。大鼠通过肠和肝挤压伤以及股骨骨折造成创伤。将大鼠出血直至平均动脉压达到40mmHg,然后按1:1:1的比例随机接受标准或洗涤/过滤后的血液制品进行复苏。假手术对照组不进行复苏。进行体外全血刺激试验并进行组织病理学检查。
与标准制品相比,血液制品的洗涤改善了质量指标。此外,EV水平降低了12%至77%。通过血栓弹力图评估的凝血状态在两组中均紊乱,并在输血期间恢复正常,无显著差异。通过组织病理学评分和生化测量评估,使用洗涤/过滤后的制品并未减少器官衰竭。与假手术组相比,输血后体外免疫反应降低,但输血组之间无差异。
血液制品的过滤或洗涤改善了生化特性并减少了EV计数,同时保持了凝血能力。然而,在这种创伤和输血模型中,使用优化的血液成分并未减轻器官损伤或免疫抑制。